691 evolution "https:" "https:" "https:" "https:" "https:" "https:" "UCL" "UCL" "UCL" positions at University of Colorado
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Compensation Calculator: http://www.cu.edu/node/153125 ADA Statement: The University will provide reasonable accommodations to applicants with disabilities throughout the employment application process. To
-
Residents in the Colorado Pharmacy Residency Teaching Certificate Program. The successful candidate will engage in scholarly activities that support teaching and course development to contribute
-
. The University of Colorado provides generous leave, health plans and retirement contributions that add to your bottom line. Perks & Benefits: https://advantage.cu.edu/search Total Compensation Calculator: http
-
include development of critical clinical and research pathways, committee work, and projects aimed at improving the section and department functions. The most important duty in this realm will be to mentor
-
of Colorado system. The Longmont practice opened in 2017 and CNMs will be expected to actively participate in practice development and Promotion Examples of Work Performed: Provide full scope care
-
students, engaged in specific clinical activities. · Enhances professional growth and development through participation in educational programs, current literature, in-service meetings, and workshops
-
transplant teams to develop clinical practice protocols to develop cutting edge transplant care. o Lead and participate in scholarly projects in solid organ transplantation. · Program Development: o
-
the assessment process. Click here to view Veteran and other General Information regarding Classified Staff positions: https://www.cu.edu/cu-careers/special-instructions-classified-staff-applicants For those who
-
and retirement contributions that add to your bottom line. Perks & Benefits: https://advantage.cu.edu/search Total Compensation Calculator: http://www.cu.edu/node/153125 Equal Employment Opportunity
-
microRNA signaling in fetal growth restriction, and (2) pioneering in utero gene editing approaches to correct genetic disease before birth. Current projects include the development of CRISPR-Cas9–based base